Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 150 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| InMed Pharmaceuticals Inc | INM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.028 | -9.24% | 0.275 | 04:29:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.303 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 3 | 150 | - | 0.262 - 2.08 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:29:46 | 46 | $ 0.281 | USD |
InMed Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.82M | 6.06M | - | 4.14M | -7.95M | -1.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
InMed Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.31 | 0.337 | 0.265 | 0.3008683 | 794,504 | -0.035 | -11.29% |
| 1 Month | 0.35 | 0.4555 | 0.262 | 0.3270908 | 758,255 | -0.075 | -21.43% |
| 3 Months | 0.34 | 0.4718 | 0.262 | 0.3437867 | 382,170 | -0.065 | -19.12% |
| 6 Months | 0.74 | 0.768 | 0.262 | 0.4029799 | 322,792 | -0.465 | -62.84% |
| 1 Year | 1.19 | 2.08 | 0.262 | 0.8385393 | 602,376 | -0.915 | -76.89% |
| 3 Years | 2.95 | 19.50 | 0.2329 | 2.84 | 758,991 | -2.68 | -90.68% |
| 5 Years | 3.70 | 19.50 | 0.2329 | 2.89 | 684,501 | -3.43 | -92.57% |
InMed Pharmaceuticals Description
| InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others. |
